Atyr Pharma Inc [NASDAQ: ATYR] surged by $0.15 during the normal trading session on while it closed the day at $5.28.
Atyr Pharma Inc stock has also gained 3.33% of its value over the past 7 days. However, ATYR stock has inclined by 83.33% in the 3 months of the year. Over the past six months meanwhile, it has gained 41.18% and gained 238.46% year-on date.
The market cap for ATYR stock reached $469.94 million, with 89.00 million shares outstanding and 86.06 million shares in the current float. Compared to the average trading volume of 2.13M shares, ATYR reached a trading volume of 4524187 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Atyr Pharma Inc [ATYR]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for ATYR shares is $19.35 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ATYR stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Leerink Partners have made an estimate for Atyr Pharma Inc shares, keeping their opinion on the stock as Outperform, with their previous recommendation back on February 18, 2025. While these analysts kept the previous recommendation, Cantor Fitzgerald raised their target price to Overweight. The new note on the price target was released on January 06, 2025, representing the official price target for Atyr Pharma Inc stock. Previously, the target price had yet another raise to $17, while Wells Fargo analysts kept a Overweight rating on ATYR stock.
The Price to Book ratio for the last quarter was 6.26, with the Price to Cash per share for the same quarter was set at 0.86.
ATYR stock trade performance evaluation
Atyr Pharma Inc [ATYR] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 3.33. With this latest performance, ATYR shares gained by 11.16% in over the last four-week period, additionally plugging by 41.18% over the last 6 months – not to mention a rise of 45.86% in the past year of trading.
Atyr Pharma Inc [ATYR]: An insightful look at the core fundamentals
Return on Equity for this stock declined to -60.25%, with Return on Assets sitting at -60.25%.
